VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 30 filers reported holding VIVOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $512 | -15.1% | 1,500 | 0.0% | 0.00% | – |
Q4 2022 | $603 | -38.2% | 1,500 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $975 | -49.6% | 1,500 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $1,935 | -51.9% | 1,500 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $4,020 | -40.4% | 1,500 | -50.0% | 0.00% | -50.0% |
Q4 2021 | $6,750 | – | 3,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 162,500 | $804,000 | 0.46% |
BARD ASSOCIATES INC | 215,500 | $1,067,000 | 0.35% |
Millrace Asset Group, Inc. | 93,993 | $465,000 | 0.24% |
Archon Capital Management LLC | 215,000 | $1,064,000 | 0.12% |
Penn Capital Management Company, LLC | 223,403 | $1,106,000 | 0.11% |
GRIFFIN ASSET MANAGEMENT, INC. | 49,500 | $245,000 | 0.03% |
K2 PRINCIPAL FUND, L.P. | 64,746 | $320,000 | 0.03% |
Walleye Capital LLC | 150,000 | $743,000 | 0.02% |
WMS Partners, LLC | 16,667 | $153,000 | 0.02% |
Avalon Investment & Advisory | 189,739 | $939,000 | 0.02% |